Coredio’s AI heart failure software secures breakthrough designation

Coredio’s AI software is used to monitor HF parameters via wearables and standard blood pressure cuffs. Coredio’s AI software is used to monitor HF parameters via wearables and standard blood pressure cuffs. Heart failure affects approximately six million Americans, with prevalence projected to increase by 46% and direct medical costs to reach $53 billion by 2030. Credit: Piotr Swat / Shutterstock.com Coredio’s haemodynamic heart failure (HF) assessment software has obtained breakthrough device designation from the US Food and Drug Administration (FDA). The California-based digital health company’s cardiac performance simulation engine (CPSE) is designed to provide clinicians with a means to…

Source: Medical Device Network